Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03581292
What this trial is testing

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Who this might be right for
Anaplastic AstrocytomaGlioblastomaMalignant Glioma
National Cancer Institute (NCI) 38
Large-scale testing (Phase 3)Study completedNCT02667587
What this trial is testing

An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Who this might be right for
Brain Neoplasms
Bristol-Myers Squibb 716
Not applicableWithdrawnNCT03956706
What this trial is testing

Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas

Who this might be right for
GlioblastomaAstrocytoma, Grade IIIAstrocytoma, Grade IV+1 more
Northwell Health
Early research (Phase 1)Study completedNCT00003463
What this trial is testing

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Not applicableUnknownNCT05811793
What this trial is testing

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

Who this might be right for
Glioblastoma
Second Affiliated Hospital of Nanchang University 36
Testing effectiveness (Phase 2)WithdrawnNCT04118036
What this trial is testing

Abemaciclib + Pembrolizumab In Glioblastoma

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute
Early research (Phase 1)Active Not RecruitingNCT06632236
What this trial is testing

5G-EMERALD: Amivantamab in Malignant Brain Tumours

Who this might be right for
Malignant Primary GliomasGlioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-Mutant+1 more
Institute of Cancer Research, United Kingdom 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05781321
What this trial is testing

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

Who this might be right for
Glioblastoma
Mayo Clinic 170
Testing effectiveness (Phase 2)Ended earlyNCT02046187
What this trial is testing

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma (GBM)
St. Joseph's Hospital and Medical Center, Phoenix 14
Early research (Phase 1)Looking for participantsNCT06186401
What this trial is testing

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Who this might be right for
EGFR Gene MutationGlioblastomaMGMT-Unmethylated Glioblastoma+1 more
Hideho Okada, MD, PhD 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06061809
What this trial is testing

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
ImmunityBio, Inc. 34
Testing effectiveness (Phase 2)Looking for participantsNCT06011109
What this trial is testing

Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Who this might be right for
GliomaGlioblastoma Multiforme
Aveta Biomics, Inc. 30
Not applicableActive Not RecruitingNCT05970757
What this trial is testing

Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma

Who this might be right for
Glioblastoma
Erasmus Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT04469699
What this trial is testing

Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme, Adult
University Hospital Muenster 30
Testing effectiveness (Phase 2)Study completedNCT00014300
What this trial is testing

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 32
Testing effectiveness (Phase 2)Study completedNCT01220271
What this trial is testing

A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioma
Eli Lilly and Company 75
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Testing effectiveness (Phase 2)Ended earlyNCT05753007
What this trial is testing

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Who this might be right for
Glioblastoma
Mclean Hospital 2
Testing effectiveness (Phase 2)Looking for participantsNCT06810544
What this trial is testing

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Who this might be right for
Non Small Cell Lung CancerGlioma Glioblastoma MultiformeGlioma, Malignant+4 more
Tango Therapeutics, Inc. 191
Early research (Phase 1)Study completedNCT03603379
What this trial is testing

Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas

Who this might be right for
Glioblastoma
University Hospital, Basel, Switzerland 9
Next Page